Industry

DUBLIN–(BUSINESS WIRE)–The “Pulse Oximeter Market Research Report by Type (Fingertip Pulse Oximeter and Handheld Pulse Oximeter), End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Pulse Oximeter Market size was estimated at USD 2,477.41 … [Read more…]

A team of scientists at Institute of Protein Design led by David Baker, Ph.D., and ARCH Venture Partners launch Vilya to create a new transformational class of medicines Paper published today in Cell describes the ground-breaking research behind Vilya’s foundational technology leveraging advanced computational approaches to design novel molecules, never before found in nature, with … [Read more…]

The Company strengthens its healthy foods benefit offering to health plans by advancing post-discharge meal capabilities and expanding meal offerings. FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–#DeliverLean–NationsBenefits®, a leading provider of supplemental benefits, flex cards, and member engagement solutions for health plans, announced today an agreement to acquire DeliverLean™, one of the country’s largest food manufacturers specializing in … [Read more…]

Conference to Connect Medtech Leaders at the Forefront of Healthcare Innovation STANFORD, Calif.–(BUSINESS WIRE)–MedtechWomen today announced its tenth annual MedtechVision Conference, designed by and for women at the forefront of medical innovation. The conference, which is presented by MedtechWomen in partnership with Stanford Byers Center for Biodesign, will be held on Friday, September 9, 2022 … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Fatty Acid Amide Hydrolase (FAAH) Inhibitor – Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. “Fatty Acid Amide Hydrolase (FAAH) Inhibitor – Pipeline Insight, 2022” report by the publisher offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Fatty Acid Amide Hydrolase (FAAH) Inhibitor development. … [Read more…]

Strengthens Long-Standing Presence in the Midwestern U.S. and Brings New Customers, Executive Talent, and Sales and Service Personnel to U.S. Dental Distribution Business MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced the acquisition of Midway Dental Supply, a full-service dental … [Read more…]

This partnership enables Martin’s Point to close care gaps and better address the care needs of senior populations looking to age in place. FRANKLIN, Tenn.–(BUSINESS WIRE)–PopHealthCare and its national value-based medical group, Emcara Health, today announced a partnership with Martin’s Point to deliver comprehensive health assessments and risk adjustment services for more than 58,000 Generations … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Optometry Equipment Market by Type (OCT, Ophthalmoscope, Autorefractor, Tonometer, Slitlamps, Wavefront Analyzer), Application(General Examination, Cataract, Glaucoma, Macular Degeneration), End User(Clinics, Hospitals) – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The global optometry equipment market is projected to reach USD 5.4 billion by 2027, from USD 4.0 billion in 2022, … [Read more…]

NEW YORK–(BUSINESS WIRE)–Summer is winding down and college students across the country are settling into their dorms and new class schedule for the fall semester. As routines and in some cases climates change drastically for these students, Shirin Peters, M.D., Founder of Bethany Medical Clinic, offers her tips to help college students ensure they keep … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Genome Insight, a cancer whole genome platform company, is launching a pilot program in Ajou University Medical Center to test the use of Whole Genome Sequencing (WGS) in routine cancer care setting. Cancer patients at various stages in the treatment journey will be eligible to receive WGS testing if the clinician notices potential … [Read more…]